Akso Health Group current report, Q1 FY2020

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K is a report of a foreign private issuer filed by Hexindai Inc. for the month of January 2020. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Rui (Kerrie), Chief Financial Officer, on January 17, 2020. The filing includes Exhibit 99.1, which is a Press Release.

Financial Metrics

The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity in this document.

Material Changes

The filing text does not provide information regarding material changes versus the prior comparable period.

Guidance, Outlook, and Risks

The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The content is limited to the cover page, signature block, and exhibit index.

Key Facts for Investor Verification

  • The filing is a Form 6-K referencing a Press Release (Exhibit 99.1) which is not included in the provided text.
  • No financial metrics or operational updates are present in the cover document.
  • Investors must locate and review the attached Press Release (Exhibit 99.1) to obtain the actual announcement details.
  • The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.